Health
-
Despite Long COVID’s ongoing impact, research in Colombia is limited
One of the few Long COVID research studies in Colombia is testing cognitive rehabilitation therapy. This approach recently failed in a U.S. clinical trial.
-
“Medically neglected” and “structurally erased”: International network appeals for ME advocate Nevra Elis
This fall, an international group of people known as Team Nevra has led an ongoing campaign to fundraise and help find care for Nevra Elis, an advocate living with severe myalgic encephalomyelitis (ME).
-
The future of Medicaid is “really scary” for people with Long COVID
The deep cuts to Medicaid funding in the Trump administration’s spending bill of almost $1 trillion — as well as new requirements making Medicaid more difficult to obtain and maintain — will hit disadvantaged groups hard. For many with Long COVID, the cuts put their lives and well-being at risk.
-
International Long COVID conference spotlights biomarker and mechanism research
The event, now in its third year, also revealed updates about clinical trials and healthcare for the disease.
-
Less than 20% of Long COVID trials involving exercise even mention post-exertional malaise
An analysis by The Sick Times find that less than 15% of Long COVID clinical trials testing the benefits of exercise or cardiopulmonary rehabilitation measured post-exertional malaise, according to their trial registration, while a handful excluded participants who experience it.
-
Alice Wong, disability activist and luminary, dies at 51
Alice Wong platformed and uplifted people with Long COVID in her final chapter as a lifelong disability advocate and storyteller.
-
As the American West faces increasing air pollution, protecting the right to mask is vital
Utah’s proposed ban became an important case study demonstrating the overlapping concerns between airborne pathogens and environmental air pollution. It highlighted the necessity of building coalitions between environmental, health and disability, and civil liberties groups in resisting mask bans as climate change is on track to worsen a variety of environmental public health threats, not…
-
Business school competition centers Long COVID and IACCs
At this case competition in Ann Arbor, Michigan, the winning team sought to better connect people with IACCs and healthcare providers who serve them.
-
Metformin has been shown to reduce the risk of Long COVID. Why isn’t it more widely used?
Recent studies add evidence to a prior phase 3 clinical trial, suggesting that taking the diabetes drug during acute COVID-19 reduces the risk of long-term symptoms.
-
NBA player Kristaps Porziņģis shares POTS diagnosis
Earlier this week, professional basketball player Kristaps Porziņģis shared his diagnosis of postural orthostatic tachycardia syndrome (POTS). The 30-year-old player began facing severe health challenges this spring while playing for…
Follow Us
get the latest long covid news
Trending
Recent ARTICLES
-
HHS hosts event and announces new initiatives for Lyme disease, but advocates are skeptical about follow-through
-
Research updates, December 16
-
Despite Long COVID’s ongoing impact, research in Colombia is limited
-
National COVID-19 trends, December 16
-
“Medically neglected” and “structurally erased”: International network appeals for ME advocate Nevra Elis
Tags
advocacy arts CDC clinical trials COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health Q&A research update science Trump administration updates and events vaccines wastewater surveillance